185 related articles for article (PubMed ID: 18924147)
21. Evaluation of the developmental toxicity of 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl) ethanone (OTNE) in rats.
Politano VT; Letizia CS; Christian MS; Diener RM; Api AM
Int J Toxicol; 2009; 28(3):213-8. PubMed ID: 19546259
[TBL] [Abstract][Full Text] [Related]
22. Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?
Markowitz JS; Patrick KS
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S54-61. PubMed ID: 18480678
[TBL] [Abstract][Full Text] [Related]
23. Early exposure to methylphenidate increases fear responses in an aversive context in adult rats.
Britton GB; Segan AT; Sejour J; Mancebo SE
Dev Psychobiol; 2007 Apr; 49(3):265-75. PubMed ID: 17380504
[TBL] [Abstract][Full Text] [Related]
24. Methylphenidate increases creatine kinase activity in the brain of young and adult rats.
Scaini G; Fagundes AO; Rezin GT; Gomes KM; Zugno AI; Quevedo J; Streck EL
Life Sci; 2008 Dec; 83(23-24):795-800. PubMed ID: 18938183
[TBL] [Abstract][Full Text] [Related]
25. Endocrine effects of tetrabromobisphenol-A (TBBPA) in Wistar rats as tested in a one-generation reproduction study and a subacute toxicity study.
Van der Ven LT; Van de Kuil T; Verhoef A; Verwer CM; Lilienthal H; Leonards PE; Schauer UM; Cantón RF; Litens S; De Jong FH; Visser TJ; Dekant W; Stern N; Håkansson H; Slob W; Van den Berg M; Vos JG; Piersma AH
Toxicology; 2008 Mar; 245(1-2):76-89. PubMed ID: 18255212
[TBL] [Abstract][Full Text] [Related]
26. Maternal and developmental toxicity study of sodium azide in rats.
Faqi AS; Richards D; Hauswirth JW; Schroeder R
Regul Toxicol Pharmacol; 2008 Nov; 52(2):158-62. PubMed ID: 18755233
[TBL] [Abstract][Full Text] [Related]
27. Toxicokinetic assessment of methylphenidate (Ritalin(R)) in a 13-week oral (gavage) toxicity study in rats using an enantiomeric liquid chromatography/tandem mass spectrometry assay.
Bakhtiar R; Tse FL
Rapid Commun Mass Spectrom; 2003; 17(18):2160-2. PubMed ID: 12955748
[No Abstract] [Full Text] [Related]
28. Studies of the toxicological potential of capsinoids: IX. Teratology studies of dihydrocapsiate in rats and rabbits.
Bernard BK; Watanabe E; Kodama T; Tsubuku S; Otabe A; Ikeya M; Matsuoka T; Masuyama T
Int J Toxicol; 2008; 27 Suppl 3():119-36. PubMed ID: 19037803
[TBL] [Abstract][Full Text] [Related]
29. [Differences in neuronal toxicity and its molecular mechanisms between methamphetamine and methylphenidate].
Narita M; Asato M; Shindo K; Kuzumaki N; Suzuki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):115-20. PubMed ID: 19663261
[TBL] [Abstract][Full Text] [Related]
30. Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs.
Thai DL; Yurasits LN; Rudolph GR; Perel JM
Drug Metab Dispos; 1999 Jun; 27(6):645-50. PubMed ID: 10348792
[TBL] [Abstract][Full Text] [Related]
31. General 4-week toxicity study with EMS in the rat.
Pfister T; Eichinger-Chapelon A
Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
[TBL] [Abstract][Full Text] [Related]
32. [Teratogenicity study of 2,2,3,3,3-pentafluoro-1-propanol (5FP) in rats by oral administration].
Usami M; Sakemi K; Kurebayashi H; Ohno Y
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2000; (118):45-9. PubMed ID: 11534126
[TBL] [Abstract][Full Text] [Related]
33. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.
Ponsa I; Ramos-Quiroga JA; Ribasés M; Bosch R; Bielsa A; Ordeig MT; Morell M; Miró R; de Cid R; Estivill X; Casas M; Bayés M; Cormand B; Hervás A
Mutat Res; 2009 Jun; 666(1-2):44-9. PubMed ID: 19457516
[TBL] [Abstract][Full Text] [Related]
34. Investigation of possible teratogenic effects in the offspring of mice exposed to methylphenidate during pregnancy.
Costa Gde A; Galvão TC; Bacchi AD; Moreira EG; Salles MJ
Reprod Biomed Online; 2016 Feb; 32(2):170-7. PubMed ID: 26687907
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 mice.
Manjanatha MG; Shelton SD; Dobrovolsky VN; Shaddock JG; McGarrity LG; Doerge DR; Twaddle NW; Lin CJ; Chen JJ; Mattison DR; Morris SM
Environ Mol Mutagen; 2008 Oct; 49(8):585-93. PubMed ID: 18618596
[TBL] [Abstract][Full Text] [Related]
36. The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor.
Markowitz JS; DeVane CL; Ramamoorthy S; Zhu HJ
Pharmazie; 2009 Feb; 64(2):123-5. PubMed ID: 19322953
[TBL] [Abstract][Full Text] [Related]
37. Effects of low-level arsenic exposure on the developmental toxicity of anilofos in rats.
Aggarwal M; Wangikar PB; Sarkar SN; Rao GS; Kumar D; Dwivedi P; Malik JK
J Appl Toxicol; 2007; 27(3):255-61. PubMed ID: 17304642
[TBL] [Abstract][Full Text] [Related]
38. Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats.
Patil RD; Dwivedi P; Sharma AK
Reprod Toxicol; 2006 Nov; 22(4):679-87. PubMed ID: 16781114
[TBL] [Abstract][Full Text] [Related]
39. DNA damage in rats after treatment with methylphenidate.
Andreazza AC; Frey BN; Valvassori SS; Zanotto C; Gomes KM; Comim CM; Cassini C; Stertz L; Ribeiro LC; Quevedo J; Kapczinski F; Berk M; Gonçalves CA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1282-8. PubMed ID: 17614179
[TBL] [Abstract][Full Text] [Related]
40. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development.
Burdan F; Szumilo J; Klepacz R
Reprod Toxicol; 2009 Sep; 28(2):239-44. PubMed ID: 19379806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
